These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 27491498

  • 1. Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network study.
    Huerter MM, Meza JL, Copur MS, Tolentino A, Marr AS, Ketcham M, DeSpiegelaere H, Kruse S, Kos ME, Swenson K, Radniecki SE, Kessinger A, Ganti AK.
    J Geriatr Oncol; 2017 Jan; 8(1):18-22. PubMed ID: 27491498
    [Abstract] [Full Text] [Related]

  • 2. First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
    Kourousis C, Androulakis N, Kakolyris S, Souglakos J, Maltezakis G, Metaxaris G, Chalkiadakis G, Samonis G, Vlachonikolis J, Georgoulias V.
    Cancer; 1998 Nov 15; 83(10):2083-90. PubMed ID: 9827712
    [Abstract] [Full Text] [Related]

  • 3. Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancer.
    Takatani H, Nakamura Y, Nagashima S, Soda H, Kinoshita A, Fukuda M, Fukuda M, Soejima Y, Kasai T, Nakatomi K, Iida T, Oka M, Tsukamoto K, Kohno S.
    Clin Lung Cancer; 2012 Sep 15; 13(5):347-51. PubMed ID: 22264660
    [Abstract] [Full Text] [Related]

  • 4. Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer.
    Masters GA, Hahn EA, Shevrin DH, Kies MS.
    Lung Cancer; 2003 Feb 15; 39(2):221-6. PubMed ID: 12581577
    [Abstract] [Full Text] [Related]

  • 5. Randomized phase II study of paclitaxel and carboplatin or vinorelbine in advanced non-small cell lung cancer.
    Jahnke K, Keilholz U, Lüftner D, Thiel E, Schmittel A.
    Anticancer Res; 2011 Jan 15; 31(1):317-23. PubMed ID: 21273617
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401.
    Takayama K, Inoue K, Tokunaga S, Matsumoto T, Oshima T, Kawasaki M, Imanaga T, Kuba M, Takeshita M, Harada T, Shioyama Y, Nakanishi Y.
    Cancer Chemother Pharmacol; 2013 Dec 15; 72(6):1353-9. PubMed ID: 24166107
    [Abstract] [Full Text] [Related]

  • 7. Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC--a phase II trial.
    Babiak A, Hetzel J, Godde F, König HH, Pietsch M, Hetzel M.
    Br J Cancer; 2007 Apr 10; 96(7):1052-6. PubMed ID: 17353918
    [Abstract] [Full Text] [Related]

  • 8. A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer.
    Soejima K, Naoki K, Ishioka K, Nakamura M, Nakatani M, Kawada I, Watanabe H, Nakachi I, Yasuda H, Satomi R, Nakayama S, Yoda S, Ikemura S, Terai H, Sato T, Ohgino K, Arai D, Tani T, Kuroda A, Nishino M, Betsuyaku T.
    Cancer Chemother Pharmacol; 2015 Mar 10; 75(3):513-9. PubMed ID: 25563719
    [Abstract] [Full Text] [Related]

  • 9. Concurrent chemoradiation with cisplatin and vinorelbine followed by consolidation with oral vinorelbine in locally advanced non-small cell lung cancer (NSCLC): the phase II CONCAVE study.
    Hughes BG, Ahern E, Lehman M, Pratt G, Dauth M, Pritchard W, Wockner L, Horwood K.
    Asia Pac J Clin Oncol; 2017 Jun 10; 13(3):137-144. PubMed ID: 28181415
    [Abstract] [Full Text] [Related]

  • 10. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.
    Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Bennouna J, Tredaniel J, Ducoloné A, Lebitasy MP, Baudrin L, Laporte S, Milleron B, Intergroupe Francophone de Cancérologie Thoracique.
    Lancet; 2011 Sep 17; 378(9796):1079-88. PubMed ID: 21831418
    [Abstract] [Full Text] [Related]

  • 11. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD, Burris HA, Morrissey LH, Thomas M, Erland JB, Butts JA, Joseph G, Kalman L, Greco FA.
    Cancer J; 2000 Sep 17; 6(3):151-6. PubMed ID: 10882330
    [Abstract] [Full Text] [Related]

  • 12. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lena MD, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J.
    Lung Cancer; 2005 Apr 17; 48(1):129-35. PubMed ID: 15777980
    [Abstract] [Full Text] [Related]

  • 13. Triplet platinum-based combination sequential chemotherapy improves survival outcome and quality of life of advanced non-small cell lung cancer patients.
    Chen LK, Liang Y, Yang QY, Xu F, Zhou NN, Xu GC, Liu GZ, Wei WD.
    Asian Pac J Cancer Prev; 2012 Apr 17; 13(5):1863-7. PubMed ID: 22901137
    [Abstract] [Full Text] [Related]

  • 14. Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO).
    Vansteenkiste J, Barlesi F, Waller CF, Bennouna J, Gridelli C, Goekkurt E, Verhoeven D, Szczesna A, Feurer M, Milanowski J, Germonpre P, Lena H, Atanackovic D, Krzakowski M, Hicking C, Straub J, Picard M, Schuette W, O'Byrne K.
    Ann Oncol; 2015 Aug 17; 26(8):1734-40. PubMed ID: 25939894
    [Abstract] [Full Text] [Related]

  • 15. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995 Aug 17; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 16. An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Spigel DR, Luft A, Depenbrock H, Ramlau R, Khalil M, Kim JH, Mayo C, Chao GY, Obasaju C, Natale R.
    Clin Lung Cancer; 2017 Sep 17; 18(5):480-488. PubMed ID: 28365238
    [Abstract] [Full Text] [Related]

  • 17. Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2.
    Kosmidis PA, Syrigos K, Kalofonos HP, Dimopoulos MA, Skarlos D, Pavlidis N, Boukovinas I, Bafaloukos D, Pectasides D, Bacoyiannis C, Fountzilas G.
    Anticancer Res; 2012 Jan 17; 32(1):175-81. PubMed ID: 22213304
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC).
    Pereira JR, Martins SJ, Nikaedo SM, Ikari FK.
    BMC Cancer; 2004 Sep 29; 4():69. PubMed ID: 15456520
    [Abstract] [Full Text] [Related]

  • 19. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
    Reck M, Macha HN, Del Barco S, Cornes P, Vaissière N, Morand M, Riggi M, Abratt R.
    Lung Cancer; 2009 Jun 29; 64(3):319-25. PubMed ID: 19095327
    [Abstract] [Full Text] [Related]

  • 20. Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.
    Attia S, Traynor AM, Kim K, Merchant JJ, Hoang T, Ahuja HG, Beatty PA, Hansen RM, Masters GA, Oettel KR, Shapiro GR, Larson MM, Larson ML, Schiller JH.
    J Thorac Oncol; 2008 Sep 29; 3(9):1018-25. PubMed ID: 18758305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.